Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated diseaseActive, not recruitingPhase 32026-10-09NCT05063162

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

55 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Mog001 20032Suita-shiJapan1
Mog001 20049Kitakyushu-shiJapan1
Mog001 20068ChibaJapan1
Mog001 20070Shinjuku-kuJapan1
Mog001 20143KodairaJapan1
Mog001 20223Koriyama-shiJapan1
Mog001 20224SendaiJapan1
Mog001 20226Goyang-siSouth Korea1
Mog001 20227SendaiJapan1
Mog001 20228TernopilUkraine1
Mog001 20307IseharaJapan1
Mog001 20319KyivUkraine1
Mog001 30022MelbourneAustralia1
Mog001 40049SevilleSpain1
Mog001 40140GöttingenGermany1
Mog001 40146PaviaItaly1
Mog001 40161MadridSpain1
Mog001 40163OxfordUnited Kingdom1
Mog001 40170StrasbourgFrance1
Mog001 40177MünsterGermany1
Mog001 40185GhentBelgium1
Mog001 40195Hradec KrálovéCzechia1
Mog001 40267BarcelonaSpain1
Mog001 40337BernSwitzerland1
Mog001 40341MálagaSpain1